United States Flag

An official website of the United States government. Here's how you know >

Skip Navigation Change Font Size

Archives - Food and Drug Administration (FDA)

FY 2004

09-20-2004
Review of Food and Drug Administration's Bone Mass Study (A-03-03-00378)

Top

FY 2002

02-13-2002
Review of the Accuracy of the Food and Drug Administration's Official Establishment Inventory (A-15-01-20001)

Top

FY 2001

05-03-2001
Reporting Abuses of Persons with Disabilities (A-01-00-02502)

Top

FY 2000

12-14-1999
Review of the Food and Drug Administration's Handling of Adverse Drug Reaction Reports (A-15-98-50001)

Top

FY 1999

09-01-1999
Review of the Food and Drug Administration's Cost Increases for the Arkansas Regional Laboratory (A-15-98-50002)

Top

FY 1998

07-17-1998
Review of the Annual Reporting Process for Investigational New Drugs Regulated by the Food and Drug Administration's Center for Biologics Evaluation and Research (A-15-96-50001)
07-17-1998
Review of the Food and Drug Administration's Citizen Petition Process (A-15-97-50002)
03-02-1998
Review of the Food and Drug Administration's Internal Controls Over Its Purchase Card Activities (A-15-97-80002)

Top

FY 1997

06-04-1997
Review of the Food and Drug Administration's Inspection Process of Plasma Fractionators (A-03-97-00350)
05-16-1997
Review of the Food and Drug Administration's Handling of Issues Related to Conjugated Estrogens (A-15-96-50002)
05-05-1997
Compliance with the Prompt Payment Act by the Food and Drug Administration (A-15-96-40002)

Top

FY 1996

04-12-1996
Review of the Food and Drug Administration's Processing of 17 Error and Accident Reports Involving Blood (A-03-95-00350)
03-06-1996
Review of the Food and Drug Administration's Processes to Review Medical Device Submissions Under the Pre-Market Approval and Investigational Device Exemption Programs (A-15-95-50001)

Top

FY 1995

09-25-1995
Report on the Audit of the Food and Drug Administration's Revolving Fund for Certification and Other Services for Fiscal Year 1994 (A-17-94-00040)
09-25-1995
Report on the Audit of the Food and Drug Administration's Prescription Drug User Fee Account for Fiscal Year 1994 (A-17-95-00046)
08-02-1995
Review of the Food and Drug Administration's Processing of a New Drug Application for Therafectin (A-15-94-00023)
Reporting Process for Blood Establishments to Notify the Food and Drug Administration of Errors and Accidents Affecting Blood (A-03-93-00352)

Top

FY 1994

09-29-1994
Follow-up Review of Possible Improper Pre-Approval Promotion Activities (A-15-93-00018)

Top

FY 1993

08-27-1993
Financial Audit of the Food and Drug Administration's Revolving Fund for Certification and Other Services (A-15-93-00007)
06-07-1993
Review of the Food and Drug Administration's Headquarters Imprest Fund (A-15-92-00019)
02-26-1993
Follow-Up Review On Internal Control Weaknesses in the Food and Drug Administration's Medical Device 510(k) Review Process (A-03-92-00605)
10-26-1992
Follow-up Review of the Food and Drug Administration's Generic Drug Management Information System (A-15-91-00026)

Top

FY 1992

09-16-1992
Follow-Up Review of the Food and Drug Administration's Generic Drug Approval Process (A-15-91-00025)
08-06-1992
Review of Allegations of Mismanagement at the Food and Drug Administration - Newark District Office (A-02-91-02522)
02-21-1992
Audit of Issues Related to the Food and Drug Administration Review of Bovine Somatotropin (A-15-90-00046)

Top

Return to Archives

I'm Looking For

Let's start by choosing a topic

Exclusions Database Report Fraud

Office of Inspector General, U.S. Department of Health and Human Services | 330 Independence Avenue, SW, Washington, DC 20201